API
CPPL / Products / API
Our APIs Commercial Products
Click on products to raise query related to that product.
| Product name | Grade | Therapeutic Category | Cas Number | Commercially Available | Detail |
|---|---|---|---|---|---|
| Atorvastatin | IP/BP/USP | Anti-Cholesterol | 134523-03-8 | Yes | Know More |
| Azithromycin | IP/BP/EP/USP | Broad-Spectrum Antibiotic | 83905-01-5 | Yes | Know More |
| Citicoline sodium | IH/IP/USP | Nootropic, Psychostimulants | 33818-15-4 | Yes | Know More |
| Deflazacort | IH | Anti-inflammatory / Immunosuppressant | 14484-47-0 | Yes | Know More |
| Dorzolamide | IP/BP/USP | Topical Beta Blockers | 130693-82-2 | Yes | Know More |
| Emtricitabine | IP/BP/USP | Nucleoside Transcriptase Inhibitor | 143491-57-0 | Yes | Know More |
| Fenofibrate | IP/BP/USP | Anti-Cholesterol | 49562-28-9 | Yes | Know More |
| Fexofenadine hydrochloride | IP/BP/USP | Anti-Histamines | 153439-40-8 | Yes | Know More |
| Fluconazole | IP/BP/USP | Anti-Fungal/Triazoles | 86386-73-4 | Yes | Know More |
| Mirabegron | IP/EP/IH | Beta-3 adrenergic agonists | 223673-61-8 | Yes | Know More |
| Montelukast Sodium | IP/EP/USP | Anti-Asthmatic / Anti-Allergic | 151767-02-1 | Yes | Know More |
| Nitrofurantoin | IP/BP/USP | Antibiotic/Anti-Bacterial | 67-20-9 | Yes | Know More |
| Pantoprazole | IP / BP / USP | Proton Pump Inhibitor / Anti-Ulcer | 102625-70-7 | Yes | Know More |
| Rosuvastatin Calcium | IP / EP / USP | Antilipemic Agent / Statin | 147098-20-2 | Yes | Know More |
| Sacubitril | IP/BP/USP | Used to Treat Heart Failure | 149709-62-6 | Yes | Know More |
| Sacubitril Valsartan sodium | IP/BP/USP | Used to Treat Heart Failure | 936623-90-4 | Yes | Know More |
| Sildenafil citrate | IP/EP/USP | Erectile Dysfunction | 171599-83-0 | Yes | Know More |
| Tadalafil Citrate | IP/BP/USP | Erectile Dysfunction | 171596-29-5 | Yes | Know More |
| Tigecycline | IP/BP/USP | Antibiotic/Anti-Bacterial | 220620-09-7 | Yes | Know More |
Disclaimer: Patented products are available for R&D purposes only as permitted under 35 U.S.C section 271 (e) (I).
